Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Buy Rubicon Research; target of Rs 1160: Motilal Oswal
Motilal Oswal is bullish on Rubicon Research recommended buy rating on the stock with a target price of Rs 1160 in its research report dated May 30, 2026.
Neutral Lupin; target of Rs 2520: Motilal Oswal
Motilal Oswal recommended Neutral rating on Lupin with a target price of Rs 2520 in its research report dated May 10, 2026.
Buy Ipca Laboratories; target of Rs 1730: Motilal Oswal
Motilal Oswal is bullish on Ipca Laboratories recommended buy rating on the stock with a target price of Rs 1730 in its research report dated June 01, 2026.
Buy Glenmark Pharma; target of Rs 2610: Motilal Oswal
Motilal Oswal is bullish on Glenmark Pharma recommended buy rating on the stock with a target price of Rs 2610 in its research report dated June 01, 2026.
Max Healthcare shares fall up to 7% as Q4 results miss estimates
Analysts at domestic brokerage Motilal Oswal Financial Services said the earnings miss was due to a higher tax rate .
Stocks to Watch Today: NLC India, IRB Infrastructure, Rail Vikas Nigam, JNK India, Bharti Airtel, Vodafone Idea, NRB Bearings in focus on 09 June
Stocks to Watch, 09 June: Stocks like NLC India, IRB Infrastructure Developers, Panacea Biotec, Grasim Industries, HCL Technologies, Rail Vikas Nigam, JNK India, Motilal Oswal Financial Services, and NRB Bearings will be in focus on June 9.
HDFC Life buys Rs 153 crore Motilal Oswal Financial shares, promoter sells 4.5% stake in NRB Bearings
Motilal Oswal Healthcare Foundation, and Motilal Oswal Foundation were sellers in Motilal Oswal Financial Services shares.
Neutral Zydus LifeSciences; target of Rs 1080: Motilal Oswal
Motilal Oswal recommended Neutral rating on Zydus LifeSciences with a target price of Rs 1080 in its research report dated May 20, 2026.
Buy Dr Agarwals Health Care; target of Rs 610: Motilal Oswal
Motilal Oswal is bullish on Dr Agarwals Health Care recommended buy rating on the stock with a target price of Rs 610 in its research report dated Jun 05, 2026.
Neutral Blue Star; target of Rs 1920: Motilal Oswal
Motilal Oswal recommended Neutral rating on Blue Star with a target price of Rs 1920 in its research report dated May 07, 2026.
Buy Ajanta Pharma; target of Rs 3400: Motilal Oswal
Motilal Oswal is bullish on Ajanta Pharma has recommended buy rating on the stock with a target price of Rs 3400 in its research report dated May 05, 2026.
Buy Laurus Labs; target of Rs 1370: Motilal Oswal
Motilal Oswal is bullish on Laurus Labs has recommended buy rating on the stock with a target price of Rs 1370 in its research report dated April 30, 2026.